
Frontiers in Digital Health, Journal Year: 2025, Volume and Issue: 7
Published: Feb. 27, 2025
This Research Topic gathers different contributions addressing the practical advancement of concept digital twins in medicine, moving it form a vague theoretical towards foundation to tools used everyday healthcare. The twin (sometimes known as virtual twin) is that mainstream manufacturing, where representation created an intended or actual real-world physical product, system, process (the twin). serves effectively indistinguishable counterpart and for purposes such simulation, monitoring maintenance (Singh et al., 2021). has existed medicine decades, but unlike industry, not found its way dayto-day application patient care (Venkatesh 2022;Derraz 2024). Despite this there renewed research interest theme.The goal was address if we are at dawn medical practice explore what needed realize this. articles help define aspects near translation those need substantially more preclinical development before possible. Digital Twins patients, which have been defined various ways "a viewable replica patient, organ, biological system contains multidimensional, patient-specific information informs decisions" (Drummond Gonsard, 2024), involve only new forms about also simulation methods often AI-based predictive analytical methods. There much hype excitation AI, AI will delivery promise firmly linked status datain other words twin. These raise regulatory ethical questions, with differing approaches countries -a bring some clarity these challenges alongside proposed strategies developments, serve description state art path impact medicine. provisional file, final typesetThe first article (Laubenbacher 2024) clinicians data-driven decision support clear, already use. 60 authors describe similarity-based approach matches patients similar historical 61 cases predict treatment outcomes. Requirements were from scientific technical literature 62 four-layer implemented. suggests multi-line 63 integration external evidence transparency data processing logic. sets 64 initial clinical evaluation illustrates through detailed 65 exemplary use case multiple myeloma. 66The third (Zhang original describes 67 framework type 2 diabetes integrates machine learning multiomic data, 68 both knowledge graphs mechanistic models. researchers developed 69 models forecast disease progression using substantial dataset comprising 70 measurements profiles. Knowledge employed interpret provide 71 context relationships. Promise demonstrated modeling reaffirming 72 targetable mechanisms features. potential DT 73 precision 74The mini review role 75 personalized therapeutics pharmaceutical manufacturing (Fischer set out 76 how pave way, systems improved 77 (as described previous three articles) facilitate 78 their management, analysis, interpretation 79 data. identify gaps be filled can part routine
Language: Английский